Ståhl, U.; Lekholm, E.; Hamnevik, E.; Fredriksson, R.; Shridharani, S.M.; Taghetchian, K.; Cohen, J.L.; Nestor, M.S.; Liljegren Sundberg, Å.
RelabotulinumtoxinA, a Ready-to-Use Formulation Neuromodulator Manufactured with PEARL™ Technology to Maintain High Biological and Specific Activity. Toxins 2025, 17, 501.
https://doi.org/10.3390/toxins17100501
AMA Style
Ståhl U, Lekholm E, Hamnevik E, Fredriksson R, Shridharani SM, Taghetchian K, Cohen JL, Nestor MS, Liljegren Sundberg Å.
RelabotulinumtoxinA, a Ready-to-Use Formulation Neuromodulator Manufactured with PEARL™ Technology to Maintain High Biological and Specific Activity. Toxins. 2025; 17(10):501.
https://doi.org/10.3390/toxins17100501
Chicago/Turabian Style
Ståhl, Ulf, Emilia Lekholm, Emil Hamnevik, Robert Fredriksson, Sachin M. Shridharani, Keywan Taghetchian, Joel L. Cohen, Mark S. Nestor, and Åsa Liljegren Sundberg.
2025. "RelabotulinumtoxinA, a Ready-to-Use Formulation Neuromodulator Manufactured with PEARL™ Technology to Maintain High Biological and Specific Activity" Toxins 17, no. 10: 501.
https://doi.org/10.3390/toxins17100501
APA Style
Ståhl, U., Lekholm, E., Hamnevik, E., Fredriksson, R., Shridharani, S. M., Taghetchian, K., Cohen, J. L., Nestor, M. S., & Liljegren Sundberg, Å.
(2025). RelabotulinumtoxinA, a Ready-to-Use Formulation Neuromodulator Manufactured with PEARL™ Technology to Maintain High Biological and Specific Activity. Toxins, 17(10), 501.
https://doi.org/10.3390/toxins17100501